Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial.
第一作者:
Alexander C,Ford
第一单位:
Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK; Leeds Gastroenterology Institute, St James's University Hospital, Leeds, UK. Electronic address: A.C.Ford@leeds.ac.uk.
作者:
主题词
人类(Humans);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);肠易激综合征(Irritable Bowel Syndrome);阿米替林(Amitriptyline);英格兰(England);双盲法(Double-Blind Method);初级卫生保健(Primary Health Care);治疗结果(Treatment Outcome)
DOI
10.1016/S0140-6736(23)01523-4
PMID
37858323
发布时间
2024-02-21
- 浏览0

Lancet (London, England)
1773-1785页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文